MetaADEDB 2.0 @ LMMD
tiaprofenic acid
(GUHPRPJDBZHYCJ-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)C(c1ccc(s1)C(=O)c1ccccc1)C
Type(s)
Approved
ATC code(s)
M01AE11
Molecular Formula:
C14H12O3S
Molecular Weight:
260.308
Log P:
3.1672
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
82.61
CAS Number(s):
33005-95-7; 103667-49-8
Synonym(s)
1.
tiaprofenic acid
2.
Apo-Tiaprofenic
3.
FC 3001
4.
Flanid
5.
Novo-Tiaprofenic
6.
Nu-Tiaprofenic
7.
PMS-Tiaprofenic
8.
RU 15060
9.
Surgam
10.
Surgam SA
11.
tiaprofenic acid, calcium salt
External Link(s)
MeSHC021270
PubChem Compound5468
BindingDB223313
ChEBI32221
CHEMBLCHEMBL365795
DrugBankDB01600
DrugCentral2652
KEGGdr:D01325
Therapeutic Target DatabaseD0S7VO
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 2Canada Vigilance
OFFSIDES
2AcidosisOFFSIDES
3AgitationCanada Vigilance: 1Canada Vigilance
4AlopeciaCanada Vigilance: 1Canada Vigilance
5AmenorrheaOFFSIDES
6Angina PectorisCanada Vigilance: 2Canada Vigilance
7AngioedemaOFFSIDES
8AnuriaOFFSIDES
9ApathyOFFSIDES
10AsthmaCanada Vigilance: 1Canada Vigilance
11Blood creatine phosphokinase increasedOFFSIDES
12Blood glucose decreasedOFFSIDES
13Blood sodiumOFFSIDES
14Body TemperatureOFFSIDES
15Breast MicrocalcificationOFFSIDES
16CheilitisOFFSIDES
17Chemical and Drug Induced Liver Injury1582111
8462374
11394653
CTD
18Chest PainOFFSIDES
19Chest discomfortCanada Vigilance: 1Canada Vigilance
20Choking sensationOFFSIDES
21Chronic left ventricular failureOFFSIDES
22Chronic ulcerative colitisOFFSIDES
23Completed SuicideOFFSIDES
24ConfabulationOFFSIDES
25CyanosisCanada Vigilance: 1Canada Vigilance
OFFSIDES
26CystitisCanada Vigilance: 412505292CTD
Canada Vigilance
27Cytomegalovirus test positiveOFFSIDES
28DeafnessOFFSIDES
29DehydrationOFFSIDES
30Drug Eruptions11792017CTD
31Dysthymic DisorderOFFSIDES
32DysuriaCanada Vigilance: 1Canada Vigilance
33EczemaOFFSIDES
34Erythema MultiformeOFFSIDES
35ErythemaOFFSIDES
36Feeling abnormalOFFSIDES
37Gastric ulcerOFFSIDES
38HemiparesisOFFSIDES
39Hepatitis B positiveOFFSIDES
40HepatitisCanada Vigilance: 1Canada Vigilance
41Hypertrophic osteoarthropathyOFFSIDES
42Kidney FailureOFFSIDES
43Lupus-like syndromeOFFSIDES
44MalaiseCanada Vigilance: 1Canada Vigilance
45Memory impairmentCanada Vigilance: 1Canada Vigilance
46Mucosal erosionOFFSIDES
47Multiple drug overdose intentionalOFFSIDES
48Myoglobin blood increasedOFFSIDES
49Nail bed infectionOFFSIDES
50NauseaCanada Vigilance: 1Canada Vigilance
51NervousnessCanada Vigilance: 1Canada Vigilance
52OliguriaOFFSIDES
53PainCanada Vigilance: 2Canada Vigilance
54Pharmaceutical product complaintOFFSIDES
55PolyuriaOFFSIDES
56RhabdomyolysisOFFSIDES
57Septic ShockOFFSIDES
58Similar reaction on previous exposure to drugOFFSIDES
59Skin test positiveOFFSIDES
60Urine ketone body presentOFFSIDES
61UrticariaCanada Vigilance: 111792017CTD
Canada Vigilance
62VomitingCanada Vigilance: 1Canada Vigilance
63Vulvovaginal painCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.